United Kingdom · Question · Written question
UIN 21130
Tixagevimab/cilgavimab
Original
Introduced
20 June 2022
Last action
4 July 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
4 July 2022
Summary
To ask the Secretary of State for Health and Social Care, whether the additional testing of Evusheld has now been completed.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 June 2022
Written question
To ask the Secretary of State for Health and Social Care, whether the additional testing of Evusheld has now been completed.
Source: Commons
4 July 2022
Answer
AstraZeneca commissioned the UK Health Security Agency (UKHSA) to undertake testing into the effectiveness of Evusheld against the Omicron variants. Initial data on testing against the BA.1 and BA.2 Omicron variants has been shared with AstraZeneca.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-06-20/21130
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1471670
- uk · wq-1471670 · source updated 4 July 2022